Penny Stocks Reports for EnzymeBioSystems, Sigma Labs, NanoTech Entertainment, Anavex Life Sciences, BIRCHCLIFF, and Pharmacyte Biotech

PHOENIX, March 20, 2015 /PRNewswire/ -- Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: EnzymeBioSystems (OTCBB:ENZB), Sigma Labs (OTCMKTS:SGLB), NanoTech Entertainment (OTCMKTS:NTEK), Anavex Life Sciences (OTCMKTS:AVXL), BIRCHCLIFF (OTCMKTS:BIREF), and Pharmacyte Biotech (OTCMKTS:PMCB).

Logo - http://photos.prnewswire.com/prnh/20150123/170935

(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)

Report Highlights:

EnzymeBioSystems (OTCBB:ENZB): By the end of last trading, the EnzymeBioSystems (OTCBB:ENZB) shares declined 16.92% (or US$0.27) to US$1.32 with about 0.123 million shares exchanged hands for the session, compared to its average volume of 0.051 million shares. In 2010, the company publicly sold 1 million shares at US$0.01 apiece. At the same time, some of the shareholders who acquired the company stock when it was still a private entity also offered 10 million shares at the same price. As a result, on June 30, 2013, there were 31.5 million shares issued and outstanding. Early this month, Quattro published an updated version of the Schedule 13 and announced that between March 2 and March 6, Mr. Lindsay sold 230,540 shares for a grand total of US$355,131.74. He originally paid US$17,521.04 for these shares. Is this company running promotion by penny stock promoter?  Is there any insider trading in this company? Read full report here.

Read Full Report: http://www.Pennystocksinsiders.com/PR5/032015A/ENZB/EnzymeBioSystems.pdf

Sigma Labs Inc (OTCMKTS:SGLB): By the end of last trading, the Sigma Labs (OTCMKTS:SGLB) shares soared 13.51% (or US$0.0100) to US$0.0840 with about 4.81 million shares exchanged hands for the session, compared to its average volume of 1.29 million shares. Sigma announced that the company will conduct a launch event on April 14, to present to the world its M290 additive 3D printer for metal. The printer will contain the flagship product that got SGLB in the 3D printing spotlight in the first place -- the company's proprietary PrintRite3D technology for in-process quality assurance. Sigma ran hot in early 2014 as this was the year when PrintRite was supposed to finally get commercialized and start generating sizable revenues for the company. Is this company running promotion by penny stock promoter?  Is there any insider trading in this company? Read full report here.

Read Full Report: http://www.Pennystocksinsiders.com/PR5/032015A/SGLB/SigmaLabs.pdf

NanoTech Entertainment, Inc. (OTCMKTS:NTEK): By the end of last trading, the NanoTech Entertainment (OTCMKTS:NTEK) shares dropped 13.73% (or US$0.0035) to US$0.0220 with about 22.00 million shares exchanged hands for the session, compared to its average volume of 2.70 million shares. The company's last quarterly was published on Feb. 17. It stated the company had US$362 thousand in cash and US$2.3 million in quarterly sales. The company managed to keep sales relatively level against the previous quarter, but shrank costs of sales by 75%. Is this company running promotion by penny stock promoter?  Is there any insider trading in this company? Read full report here.

Read Full Report: http://www.Pennystocksinsiders.com/PR5/032015A/NTEK/NanoTechEntertainment.pdf

Today Pennystocksinsiders.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.

Anavex Life Sciences Corp (OTCMKTS:AVXL):

Read Full Report: http://www.Pennystocksinsiders.com/PR5/032015A/AVXL/AnavexLifeSciences.pdf

BIRCHCLIFF ENERG NEW (OTCMKTS:BIREF):

Read Full Report: http://www.Pennystocksinsiders.com/PR5/032015A/BIREF/BIRCHCLIFF.pdf

Pharmacyte Biotech Inc (OTCMKTS:PMCB):

Read Full Report: http://www.Pennystocksinsiders.com/PR5/032015A/PMCB/PharmacyteBiotech.pdf

Insider Filing Source Reference: All observations, analyses and reports are based on public information released by the U.S. Securities and Exchange Commission.

About Pennystocksinsiders.com:

Pennystocksinsiders.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.

Important Disclaimer:

Please visit Pennystocksinsiders.com/disclaimers/index.php for details.

SOURCE Pennystocksinsiders.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED